My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$DG {{ '2016-03-23T21:04:04+0000' | timeago}} • Announcement

Retailer $DG said its long-term financial growth model includes net sales growth of 7-10% and same store sales growth of 2-4%. $DG plans to increase square footage by 6-8%. $DG expects operating profit growth of 7-11% and diluted EPS growth of 10-15%. Cash from operations is expected to be 7-8% of sales and Capex is expected to be 2-3% of sales.

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

$GT {{ '2016-10-28T14:08:18+0000' | timeago}} • Webcast

$GT's cash and cash equivalents at 3Q16-end were about $1Bil. Total debt is down more than $200MM from 2Q16 and net debt is down slightly as well. The increase versus year-end reflects the normal working capital seasonality in the company's business. The increase versus the prior year period includes the impact of Venezuela's deconsolidation.

$TGNA {{ '2016-10-28T14:06:04+0000' | timeago}} • Announcement

$TGNA's BoD declared a quarterly dividend of 14 cents per share. The dividend is payable on Jan. 3, 2017 to stockholders of record on Dec. 9, 2016.

$GT {{ '2016-10-28T14:01:42+0000' | timeago}} • Webcast

$GT expects to continue its progress toward its 2020 target of $3Bil in segment operating income and $3.5-4.0Bil in returns to shareholders as part of its 2017-2020 capital allocation plan.

$BIIB {{ '2016-10-28T14:00:32+0000' | timeago}} • Announcement

$BIIB said its New Drug Application for nusinersen, investigational treatment for spinal muscular atrophy, has been accepted by the U.S. Food and Drug Administration for Priority Review, and that its Marketing Authorization Application has been validated by the European Medicines Agency. $BIIB plans to market nusinersen under brand name Spinraza.

$LEG {{ '2016-10-28T14:00:16+0000' | timeago}} • Webcast

$LEG is experiencing some softness in welded tube business. The company lost a little bit of market share, hurt by the reduction in selling price. The aerospace business was down for two quarters in a row, $LEG said.